Register for the GOMEKLI® Mentor Program

GOMEKLI Guides official logo

The GOMEKLI Patient Mentor Program, sponsored by SpringWorks Therapeutics, Inc., is a way to connect virtually with a real patient like you who is living with, or caring for someone living with NF1-PN, and may be able to relate to what you are experiencing. This program is designed for you to have a one-on-one phone call with a GOMEKLI Mentor during which you will hear their personal story of living with or caring for someone living with NF1-PN and their treatment experience with GOMEKLI. To register for the GOMEKLI Patient Mentor Program, fill out the registration below.

If you are eligible to participate in this program, Snow Companies acting on behalf of SpringWorks, will contact you to coordinate program logistics. To be eligible to participate in the program, you must be at least 18 years of age, reside in the United States, and have, or care for someone who has, a valid prescription for GOMEKLI from a healthcare provider licensed in the United States for an FDA-approved indication.

Remember your healthcare provider is your primary source of information on your condition and treatment.

Please review our Consumer Health Data Privacy Policy.

Snow Companies will manage the GOMEKLI Mentor Program on behalf of SpringWorks. SpringWorks will not receive any identifiable information about you. If you would like to learn more about your privacy policy rights or need to contact someone, please see Snow Companies Consumer Health Data Privacy Policy here.

*Indicates a required field

 

Submit
Form processing animation

Thank you for registering for the GOMEKLI Mentor Program!

GOMEKLI Guides official logo

We received your registration and will reach out to you shortly by phone or email with more details.

For more information and resources, visit www.GOMEKLI.com.

There was a problem

Please check your information and try again

Return to form

Toggle ISI
What is GOMEKLI?

GOMEKLI (mirdametinib) is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cause symptoms and cannot be completely removed by surgery.

It is not known if GOMEKLI is safe and effective in children under 2 years of age.

Important Safety Information
Before taking GOMEKLI, tell your healthcare provider about all of your medical conditions, including if you:
  • have eye problems
  • have heart problems
  • are pregnant or plan to become pregnant. GOMEKLI can harm your unborn baby.

    Females who are able to become pregnant:

    • Your healthcare provider should check to see if you are pregnant before you begin treatment with GOMEKLI.
    • Use effective birth control (contraception) during treatment with GOMEKLI and for 6 weeks after your last dose.
    • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with GOMEKLI.

    Males with female partners who are able to become pregnant:

    • Use effective birth control (contraception) during treatment with GOMEKLI and for 3 months after your last dose.
    • Tell your healthcare provider right away if your female partner becomes pregnant or thinks she may be pregnant during treatment with GOMEKLI.
  • are breastfeeding or plan to breastfeed. It is not known if GOMEKLI passes into your breastmilk.
    • Do not breastfeed during treatment with GOMEKLI and for 1 week after your last dose.
    • Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take GOMEKLI?
  • Take GOMEKLI exactly as your healthcare provider tells you to take it. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with GOMEKLI if you develop certain side effects.
  • Take GOMEKLI twice a day, about 12 hours apart, for 21 days, followed by 7 days off treatment, to complete a 28-day treatment cycle. Your healthcare provider will decide how many treatment cycles are right for you.
  • Take GOMEKLI with or without food.
  • GOMEKLI comes in two different dosage forms, GOMEKLI capsules and GOMEKLI tablets for oral suspension. Your healthcare provider will decide the dosage form and dose of GOMEKLI that is right for you.
  • If you take GOMEKLI capsules: Swallow each capsule whole with drinking water. If more than 1 capsule is required, swallow 1 capsule at a time. Do not open, break or chew the capsules.
  • If you take GOMEKLI tablets for oral suspension, either:
    • Swallow each tablet for oral suspension whole with drinking water. If more than 1 tablet is required, swallow 1 tablet at a time.

    OR

    • Disperse the tablets for oral suspension in drinking water to make a liquid (suspension) before you take or give GOMEKLI.

    See the “Instructions for Use” that come with your medicine for instructions on how to prepare and take GOMEKLI tablets for oral suspension.

    • If you miss a dose of GOMEKLI, skip the missed dose and take your next dose at your regularly scheduled time.
    • If you vomit at any time after taking GOMEKLI, do not take an additional dose. Take your next dose at your regularly scheduled time.
What are the possible side effects of GOMEKLI?

GOMEKLI may cause serious side effects, including:

  • eye problems. GOMEKLI may cause eye problems that can lead to blindness. Your healthcare provider will check your vision before and during treatment with GOMEKLI. Tell your healthcare provider right away if you get any of the following signs or symptoms of eye problems:
    • blurred vision
    • loss of vision
    • other changes to your vision
  • heart problems. GOMEKLI may lower the amount of blood pumped by your heart, which is common in children during treatment with GOMEKLI and can also be severe. Your healthcare provider will do tests before you start GOMEKLI treatment, every 3 months during your first year of treatment, and then as needed to make sure your heart is working properly. Tell your healthcare provider right away if you get any of the following signs or symptoms of heart problems:
    • coughing or wheezing
    • shortness of breath
    • swelling of your ankles and feet
    • tiredness
    • increased heart rate
  • skin problems. Skin rashes are common with GOMEKLI in both adults and children and can also be severe. GOMEKLI can also cause hair loss (alopecia). Tell your healthcare provider if you develop any of the following signs or symptoms of skin problems:
    • flat skin rash
    • raised bumps on the skin
    • skin bumps that look like acne
    • skin redness
    • itchy rash
    • peeling skin
The most common side effects of GOMEKLI in adults include:
  • diarrhea
  • nausea
  • muscle, joint, and bone pain
  • vomiting
  • tiredness

The most common severe abnormal blood tests in adults include an increased enzyme called creatine phosphokinase (CPK).

The most common side effects of GOMEKLI in children include:
  • diarrhea
  • muscle, joint, and bone pain
  • stomach (abdominal) pain
  • vomiting
  • headache
  • skin redness, swelling, or pain around the fingernails or toenails
  • nausea

The most common severe abnormal blood tests in children include decreased white blood cell (neutrophil) counts and increased CPK.

GOMEKLI may cause fertility problems in females, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all of the possible side effects of GOMEKLI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please click here Prescribing Information including Patient Information and Instructions for Use.